Showing results (121-130 of 232) with videos related to
Sort By:
Pageof 24
Dementia and Geriatric Cognitive Disorders|July 16, 2005
Dimensions of executive function in Parkinson's diseaseDaniel Weintraub, Paul J Moberg, William C Culbertson, et al.Alzheimer Disease and Associated Disorders|May 28, 2010
Lewy body dementia: caregiver burden and unmet needsJames E Galvin, John E Duda, Daniel I Kaufer, et al.Parkinsonism & Related Disorders|May 4, 2010
Lewy body dementia: the caregiver experience of clinical careJames E Galvin, John E Duda, Daniel I Kaufer, et al.The Clinical Neuropsychologist|December 14, 2011
Medication management and neuropsychological performance in Parkinson's diseaseKevin J Manning, Christina Clarke, Alan Lorry, et al.NPJ Parkinson'S Disease|April 28, 2022
Gait abnormalities and non-motor symptoms predict abnormal dopaminergic imaging in presumed drug-induced ParkinsonismWhitley W Aamodt, Jacob G Dubroff, Gang Cheng, et al.Movement Disorders Clinical Practice|October 27, 2018
Memantine and Cognition in Parkinson's Disease Dementia/Dementia With Lewy Bodies: A Meta-AnalysisLaura Brennan, Alexander Pantelyat, John E Duda, et al.Parkinsonism & Related Disorders|June 12, 2013
Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's diseaseLama M Chahine, Joseph Daley, Stacy Horn, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 27, 2007
Long-term follow-up of impulse control disorders in Parkinson's diseaseEugenia Mamikonyan, Andrew D Siderowf, John E Duda, et al.Neuron|June 14, 2002
Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synucleinBenoit I Giasson, John E Duda, Shawn M Quinn, et al.Journal of Neuroscience Research|February 19, 2000
A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's diseaseB I Giasson, R Jakes, M Goedert, et al.Pageof 24